Search - tctmd.com

Displaying 761 - 780 of 1820

Sort: Relevancy | Date

News Daily News

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

Todd Neale

November 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

Top Stories in Cardiology, November 2017

Podcast Heart Sounds

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

Presentation Controversies and Advances 2017

FFR is the Gold Standard For Revascularization Decision Making

Presenter: Matthew J. Price

November 17, 2017

Presentation Controversies and Advances 2017

FFR is NOT the Gold Standard for Revascularization Decision Making

Presenter: Paul S. Teirstein

November 17, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

Presentation Cardiovascular Interventions 2017

Latest FFR and iFR Data

Presenter: Barry D. Rutherford

November 09, 2017

News Daily News

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

L.A. McKeown

November 08, 2017

Presentation Cardiovascular Interventions 2017

FFR Tips, Tricks and Pitfalls: How to Deal with Challenging Anatomy

Presenter: Morton J. Kern

November 08, 2017

News Conference News TCT 2017

Quantitative Flow Ratio Shows Potential in Cath Lab

TCT Daily Staff

November 03, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2017

Case #3 (With Discussion): Discordance Between FFR and iFR

Presenter: William F. Fearon, Matthias Götberg, Gary S. Mintz, Allen Jeremias

November 01, 2017

Presentation TCT 2017

CT Identification of the Vulnerable Patient and Vulnerable Plaque

Presenter: Pamela S. Douglas, Jonathon A. Leipsic, James K. Min

November 01, 2017

Presentation TCT 2017

Clinical Utility of FFRct

Presenter: Pamela S. Douglas, Jonathon A. Leipsic, James K. Min

November 01, 2017

Presentation TCT 2017

The Role of CT As the First Line Test for New Onset Chest Pain

Presenter: Pamela S. Douglas, Jonathon A. Leipsic, James K. Min

November 01, 2017

Advertisement

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

TCTMD’s Top 10 Most Popular Stories for November 2017

Top Stories in Cardiology, November 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

FFR is the Gold Standard For Revascularization Decision Making

FFR is NOT the Gold Standard for Revascularization Decision Making

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Latest FFR and iFR Data

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

FFR Tips, Tricks and Pitfalls: How to Deal with Challenging Anatomy

Quantitative Flow Ratio Shows Potential in Cath Lab

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Live From Denver: TCT 2017, Day Four

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Case #3 (With Discussion): Discordance Between FFR and iFR

CT Identification of the Vulnerable Patient and Vulnerable Plaque

Clinical Utility of FFRct

The Role of CT As the First Line Test for New Onset Chest Pain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content